These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2560821)

  • 21. Electroacupuncture analgesia is mediated by stereospecific opiate receptors and is reversed by antagonists of type I receptors.
    Cheng RS; Pomeranz BH
    Life Sci; 1980 Feb; 26(8):631-8. PubMed ID: 6247596
    [No Abstract]   [Full Text] [Related]  

  • 22. Stereochemical studies on medicinal agents. 23. Synthesis and biological evaluation of 6-amino derivatives of naloxone and naltrexone.
    Jiang JB; Hanson RN; Portoghese PS; Takemori AE
    J Med Chem; 1977 Aug; 20(8):1100-2. PubMed ID: 894682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opiate receptor inhibition improves the blunted baroreflex function in conscious dogs with right-sided congestive heart failure.
    Sakamoto S; Liang CS
    Circulation; 1989 Oct; 80(4):1010-5. PubMed ID: 2551535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed postoperative latent pain sensitization revealed by the systemic administration of opioid antagonists in mice.
    Campillo A; Cabañero D; Romero A; García-Nogales P; Puig MM
    Eur J Pharmacol; 2011 Apr; 657(1-3):89-96. PubMed ID: 21300053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors.
    Pasternak GW; Childers SR; Snyder SH
    Science; 1980 May; 208(4443):514-6. PubMed ID: 6245448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 6beta-[N,N-Bis(2-chloroethyl)amino]-17-(cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan(chlornaltrexamine) a potent opioid receptor alkylating agent with ultralong narcotic antagonist actitivty.
    Portoghese PS; Larson DL; Jiang JB; Takemori AE; Caruso TP
    J Med Chem; 1978 Jul; 21(7):598-9. PubMed ID: 209185
    [No Abstract]   [Full Text] [Related]  

  • 27. Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system.
    Kim S; Wagner HN; Villemagne VL; Kao PF; Dannals RF; Ravert HT; Joh T; Dixon RB; Civelek AC
    J Nucl Med; 1997 Nov; 38(11):1726-31. PubMed ID: 9374341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice.
    Shoblock JR; Maidment NT
    Neuropsychopharmacology; 2006 Jan; 31(1):171-7. PubMed ID: 15956992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal.
    Lewanowitsch T; Irvine RJ
    Eur J Pharmacol; 2002 Jun; 445(1-2):61-7. PubMed ID: 12065195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antinociceptive action of mitragynine in mice: evidence for the involvement of supraspinal opioid receptors.
    Matsumoto K; Mizowaki M; Suchitra T; Takayama H; Sakai S; Aimi N; Watanabe H
    Life Sci; 1996; 59(14):1149-55. PubMed ID: 8831802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of selective mu-, kappa- and delta-opioid antagonists on electroshock seizure threshold in mice.
    Jackson HC; Nutt DJ
    Psychopharmacology (Berl); 1991; 103(3):380-3. PubMed ID: 1647539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiosynthesis of [18F]3-acetylcyclofoxy: a high affinity opiate antagonist.
    Channing MA; Eckelman WC; Bennett JM; Burke TR; Rice KC
    Int J Appl Radiat Isot; 1985 Jun; 36(6):429-33. PubMed ID: 2993171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats.
    Célèrier E; Laulin J; Larcher A; Le Moal M; Simonnet G
    Brain Res; 1999 Nov; 847(1):18-25. PubMed ID: 10564731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal alpha 2 adrenergic receptors in the rat.
    Guo TZ; Poree L; Golden W; Stein J; Fujinaga M; Maze M
    Anesthesiology; 1996 Oct; 85(4):846-52. PubMed ID: 8873555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anticonvulsant effects of DADLE are primarily mediated by activation of delta opioid receptors: interactions between delta and mu receptor antagonists.
    Tortella FC; Robles L; Holaday JW
    Life Sci; 1985 Aug; 37(6):497-503. PubMed ID: 2991684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Reversible binding of naloxazine and 14-hydroxydihydromorphazine with opiate receptors].
    Li LY; Ye CY; Zhang PW; Tian M; Jin YC
    Yao Xue Xue Bao; 1984 Apr; 19(4):251-5. PubMed ID: 6093431
    [No Abstract]   [Full Text] [Related]  

  • 37. Opiate receptors in the periaqueductal gray mediate analgesic effect of nitrous oxide in rats.
    Fang F; Guo TZ; Davies MF; Maze M
    Eur J Pharmacol; 1997 Oct; 336(2-3):137-41. PubMed ID: 9384225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antinociceptive properties of FR140423 mediated through spinal delta-, but not mu- and kappa-, opioid receptors.
    Ochi T; Fujii T; Motoyama Y; Goto T
    Eur J Pharmacol; 1999 Sep; 380(2-3):73-9. PubMed ID: 10513565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonism by chlornaltrexamine of some effects of delta 9-tetrahydrocannabinol in rats.
    Tulunay FC; Ayhan IH; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1981 Mar; 70(2):219-24. PubMed ID: 6266844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple opioid receptor profile in vitro and activity in vivo of the potent opioid antagonist Win 44,441-3.
    Ward SJ; Pierson AK; Michne WF
    Life Sci; 1983; 33 Suppl 1():303-6. PubMed ID: 6319882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.